Communiqués Hypha Labs, Inc.

Actions

DIGP

US2538252022

Temps Différé OTC Markets Autres places de cotation 17:07:46 04/06/2024			Varia. 5j.	Varia. 1 janv.
0,022 ^USD	-19,71 %		-18,22 %	-45,00 %

20/05	Hypha Labs, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 31 mars 2024	CI
20/05	Hypha Labs, Inc. annonce le dépôt d'un nouveau brevet	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Digipath : Change in Certifying Accountants - Form 8-K	03/10/23	PU
Digipath Announces Record Earnings of $292,533 for Recent Quarter Ended June 30	29/08/23	AQ
Digipath, Inc. Signs Agreement to Sell the Assets of Its Lab Subsidiary	05/05/23	AQ
Digipath : Material Agreement - Form 8-K	03/05/23	PU
DIGIPATH, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	03/05/23	AQ
DIGIPATH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	14/02/23	AQ
DIGIPATH, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	17/01/23	AQ
Digipath, Inc. Announces Revenue Increase of Almost 18% for the Fourth Quarter of Fiscal Year 2022	08/12/22	AQ
DIGIPATH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	16/08/22	AQ
DIGIPATH, INC. : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	26/07/22	AQ
DIGIPATH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	16/05/22	AQ
Digipath Validates and Receives Approval to Use Free DNA Removal to Test for Aspergillus	02/05/22	AQ
Digipath to Provide Product Testing for Redwood Cultivation Products, Including Mike Tyson’s New Ear Shaped Gummies, ‘Mike Bites’	04/04/22	AQ
DIGIPATH, INC. : Other Events (form 8-K)	25/03/22	AQ
Digipath Enters Into Validation Agreement with CASPR Technologies to Determine Efficacy for New Anti-Microbial Product for the Cannabis Industry	01/03/22	AQ
Digipath Announces Financial Results for Q1, 2022	15/02/22	AQ
DIGIPATH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	14/02/22	AQ
Digipath Obtains Coveted Compliance Testing License for California Laboratory	09/02/22	GL
DIGIPATH, INC. : Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	06/01/22	AQ
Digipath Announces Results for the Fiscal Year 2021	04/01/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Hypha Labs, Inc.

Actions

DIGP

US2538252022

Communiqués

Filtres